Gossamer Bio, Inc.
GOSS
$2.00
-$0.04-1.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 5.44% | -1.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.44% | -1.07% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 5.44% | -1.07% | |||
| SG&A Expenses | -7.84% | 10.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.62% | 4.86% | |||
| Operating Income | -1.89% | -6.51% | |||
| Income Before Tax | -3.38% | -10.97% | |||
| Income Tax Expenses | -- | -112.90% | |||
| Earnings from Continuing Operations | -10.93% | -7.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.93% | -7.23% | |||
| EBIT | -1.89% | -6.51% | |||
| EBITDA | -2.18% | -6.87% | |||
| EPS Basic | 44.60% | -114.18% | |||
| Normalized Basic EPS | 62.24% | -203.29% | |||
| EPS Diluted | 44.60% | -114.18% | |||
| Normalized Diluted EPS | 62.24% | -203.29% | |||
| Average Basic Shares Outstanding | 0.09% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||